Evidence map›Paper›PMID 16245076›Full record

ArticleInflammation2004

A bactericidal cecropin-A peptide with a stabilized alpha-helical structure possess an increased killing capacity but no proinflammatory activity.

Huamei Fu, Ase Björstad, Claes Dahlgren, Johan Bylund

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Inflammation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. RETRACTED: Curcumin-InjectedMolecules (Basel, Switzerland) · 2022
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Peptide antimicrobial agents.Clinical microbiology reviews · 2006
    Review
  9. Interleukin-8-derived peptide has antibacterial activity.Antimicrobial agents and chemotherapy · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Huamei FuDepartment of Rheumatology and Inflammation Research, University of Göeborg, Guldhedsgatan 10, S-413 46 Göteborg, Sweden.
Ase Björstad
Claes Dahlgren
Johan Bylund
University of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial peptides are part of the innate immune system in a variety of different species including humans. Some of these peptides have also been shown to have effects on immune competent cells such as professional phagocytes. We have recently shown that a cecropin-like peptide from Helicobacter pylori, Hp(2-20), in addition to being bactericidal possesses proinflammatory effects and can recruit and activate neutrophils as well as monocytes. It is well established that cecropins have the ability to adopt amphipathic alpha-helices, which is thought to be required for their bactericidal activity. In this study we show the same structural requirements for Hp(2-20). Breaking the helical structure of Hp(2-20) reduced the antibacterial effect and abolished its proinflammatory activity. A C-terminal truncated cecropin A peptide that highly resembles Hp(2-20) failed to activate neutrophils and computer-based structural simulations revealed a difference between the two peptides in the stability of their helical structures. A hybrid peptide with amino acid substitutions stabilizing the alpha-helical structure of the truncated cecropin A peptide did not introduce any proinflammatory activity; the bactericidal activity was, however, increased. We thus conclude that the proinflammatory effect of Hp(2-20) is a unique sequence-specific feature of the peptide and the ability to adopt a stable amphipathic helix is a necessary but not sufficient criterion for the functional dualism of the peptide.

Indexed as

Anti-Bacterial AgentsInflammationAmino Acid SequenceAntimicrobial Cationic PeptidesComputer SimulationEscherichia coliHelicobacter pyloriHumansMicrobial Sensitivity TestsModels, MolecularNADPH OxidasesNeutrophilsPeptidesProtein Structure, SecondarySuperoxidesAnti-Bacterial AgentsAntimicrobial Cationic Peptidescecropin ANADPH OxidasesPeptidesSuperoxides

Identifiers

PMID16245076
OpenAlexW2014654560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.